Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-14

Clinical Trial Update: Fenoldopam and Acute Renal Failure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fenoldopam for acute renal failure has completed, as per trial update NCT00621790.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fenoldopam (Corlopam) (fenoldopam)

Snippet

Sponsor: Università Vita-Salute San Raffaele | Conditions: Acute Renal Failure | Phase 3 | Status: COMPLETED